Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-01-06 06:53:45 UTC |
---|
Updated at | 2021-07-15 17:36:48 UTC |
---|
NP-MRD ID | NP0021613 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Leutinacin |
---|
Provided By | NPAtlas |
---|
Description | Leutinacin is found in Lentinus and Lentinula edodes. Leutinacin was first documented in 2002 (PMID: 11741948). Based on a literature review very few articles have been published on D-Eritadenine (PMID: 20412798) (PMID: 17559404) (PMID: 17214973). |
---|
Structure | [H]OC(=O)[C@]([H])(O[H])[C@]([H])(O[H])C([H])([H])N1C([H])=NC2=C1N=C([H])N=C2N([H])[H] InChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Eritadenine, (S-(r*,r*))-isomer | MeSH | Eritadenine, monosodium salt, (R-(r*,r*))-isomer | MeSH | 6-amino-alpha,beta-Dihydroxy-9H-purine-9-butanoic acid | MeSH | Eritadenine, (S-(r*,s*))-isomer | MeSH | Eritadenine | MeSH | Eritadenine, monosodium salt, (S-(r*,r*))-isomer | MeSH | Eritadenine, (R-(r*,s*))-isomer | MeSH | (2R,3R)-4-(6-Amino-9H-purin-9-yl)-2,3-dihydroxybutanoate | Generator |
|
---|
Chemical Formula | C9H11N5O4 |
---|
Average Mass | 253.2147 Da |
---|
Monoisotopic Mass | 253.08110 Da |
---|
IUPAC Name | (2R,3R)-4-(6-amino-9H-purin-9-yl)-2,3-dihydroxybutanoic acid |
---|
Traditional Name | (2R,3R)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=NC=NC2=C1N=CN2C[C@@H](O)[C@@H](O)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1 |
---|
InChI Key | LIEMBEWXEZJEEZ-INEUFUBQSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Imidazopyrimidines |
---|
Sub Class | Purines and purine derivatives |
---|
Direct Parent | 6-aminopurines |
---|
Alternative Parents | |
---|
Substituents | - 6-aminopurine
- Aminopyrimidine
- Beta-hydroxy acid
- Sugar acid
- Alpha-hydroxy acid
- Hydroxy acid
- Monosaccharide
- N-substituted imidazole
- Pyrimidine
- Imidolactam
- Heteroaromatic compound
- Azole
- Imidazole
- Secondary alcohol
- Amino acid
- Amino acid or derivatives
- 1,2-diol
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Carboxylic acid
- Amine
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Alcohol
- Organic oxygen compound
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Ctrnacta V, Fritzler JM, Surinova M, Hrdy I, Zhu G, Stejskal F: Efficacy of S-adenosylhomocysteine hydrolase inhibitors, D-eritadenine and (S)-DHPA, against the growth of Cryptosporidium parvum in vitro. Exp Parasitol. 2010 Oct;126(2):113-6. doi: 10.1016/j.exppara.2010.04.007. Epub 2010 Apr 20. [PubMed:20412798 ]
- Ctrnacta V, Stejskal F, Keithly JS, Hrdy I: Characterization of S-adenosylhomocysteine hydrolase from Cryptosporidium parvum. FEMS Microbiol Lett. 2007 Aug;273(1):87-95. doi: 10.1111/j.1574-6968.2007.00795.x. Epub 2007 Jun 7. [PubMed:17559404 ]
- Yamada T, Komoto J, Lou K, Ueki A, Hua DH, Sugiyama K, Takata Y, Ogawa H, Takusagawa F: Structure and function of eritadenine and its 3-deaza analogues: potent inhibitors of S-adenosylhomocysteine hydrolase and hypocholesterolemic agents. Biochem Pharmacol. 2007 Apr 1;73(7):981-9. doi: 10.1016/j.bcp.2006.12.014. Epub 2006 Dec 14. [PubMed:17214973 ]
- Huang Y, Komoto J, Takata Y, Powell DR, Gomi T, Ogawa H, Fujioka M, Takusagawa F: Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue D-eritadenine. Crystal structure of S-adenosylhomocysteine hydrolase complexed with D-eritadenine. J Biol Chem. 2002 Mar 1;277(9):7477-82. doi: 10.1074/jbc.M109187200. Epub 2001 Dec 10. [PubMed:11741948 ]
|
---|